COVID-19 Global Updates & Resources

The purpose of this study is to determine the efficacy of H. pylori eradication for the treatment of chronic or persistent immune thrombocytopenic purpura (ITP) patients with moderate thrombocytopenia. H. pylori can lead to increased inflammation that can exacerbate ITP symptoms.
This is a multi-center, open label, prospective randomized phase IIl study.

Republic of Korea

https://clinicaltrials.gov/ct2/show/NCT03177629?recrs=a&cond=ITP&draw=1&rank=20

Recruiting